Royalty Pharma Sub-Manager, LLC / CYTK
Royalty Pharma Sub-Manager, LLC’s Cytokinetics Inc Position
Does Royalty Pharma Sub-Manager, LLC own Cytokinetics Inc (CYTK)? Yes — 980.4K shares worth $65M (+37.40% of its 13F portfolio) as of Q1 2026.
Position Value
$65M
Q1 2026
Shares
980.4K
% of Portfolio
+37.40%
Quarters Held
1
currently held
Position History CYTK
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 980.4K | $65M | +37.40% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Royalty Pharma Sub-Manager, LLC’s full portfolio or all institutional holders of CYTK.